“…7,10 The benefits of OR derived from individual variability in analgesic response to opioids, in which various factors such as age, gender, type of cancer, changes in renal or hepatic function, or emotional status can all play a role. 11 Numerous factors, including pharmacodynamic variability, genetic variability, 12,13 neuronal changes in response to chronic opioid exposure, [14][15][16] the specific N-methyl-d-aspartate receptor activity of some opioids, 17,18 and the phenomenon of receptor blockade 19 may be involved in this mechanism. Variability in pharmacodynamic parameters includes differences in bioavailability, pharmacological interactions, different metabolism routes, and different production of active metabolites.…”